Evidence map›Paper›PMID 39584810›Full record

ReviewEpigenomics2025

Insights to aging prediction with AI based epigenetic clocks.

Joshua J Levy, Alos B Diallo, Marietta K Saldias Montivero, Sameer Gabbita, Lucas A Salas, Brock C Christensen

Abstract readReview
In one paragraph

Review in Epigenomics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. RNA 5-Methylcytosine Modification in Myocardial Fibrosis.Reviews in cardiovascular medicine · 2025
    Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Joshua J LevyDepartment of Pathology and Laboratory Medicine, Cedars Sinai Medical Center, Los Angeles, CA, USA.ORCID 0000-0001-8050-1291
Alos B DialloProgram in Quantitative Biomedical Sciences, Dartmouth College Geisel School of Medicine, Hanover, NH, USA.
Marietta K Saldias MontiveroProgram in Quantitative Biomedical Sciences, Dartmouth College Geisel School of Medicine, Hanover, NH, USA.
Sameer GabbitaDepartment of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA.
Lucas A SalasDepartment of Epidemiology, Dartmouth College Geisel School of Medicine, Hanover, NH, USA.
Brock C ChristensenDepartment of Epidemiology, Dartmouth College Geisel School of Medicine, Hanover, NH, USA.

Funding

Translational Engineering in Cancer (TEC)P30CA023108 · NCI · DARTMOUTH COLLEGE · PI Fred W Kolling IV · 1985 to 2026
$91.3M
Zhao - Proj 2P20GM130454 · NIGMS · DARTMOUTH COLLEGE · PI MICHAEL L WHITFIELD · 2019 to 2026
$27.2M
Relation Between In-utero Vitamin D and Immune Function in Early Childhood P20GM104416 · NIGMS · DARTMOUTH COLLEGE · PI SALAS DIAZ, LUCAS A · 2013 to 2022
$23.7M
Laying the Groundwork for Web-based Elemental Imaging Software: The MicroAnalysis ToolkitR24GM141194 · NIGMS · DARTMOUTH COLLEGE · PI Brian P Jackson · 2021 to 2026
$3.1M
A Multiplex Protein Biomarker-Based Immunoassay for the Early Detection of Bladder Cancer and its Implications in Tumor BiologyR01CA277810 · NCI · CEDARS-SINAI MEDICAL CENTER · PI Hideki Furuya, Charles J Rosser · 2023 to 2026
$1.6M
NCI NIH HHS P30 CA023108NCI NIH HHS R01 CA277810NIGMS NIH HHS P20 GM104416NIGMS NIH HHS P20 GM130454NIGMS NIH HHS R24 GM141194
6 · The paper itself

Abstract

Over the past century, human lifespan has increased remarkably, yet the inevitability of aging persists. The disparity between biological age, which reflects pathological deterioration and disease, and chronological age, indicative of normal aging, has driven prior research focused on identifying mechanisms that could inform interventions to reverse excessive age-related deterioration and reduce morbidity and mortality. DNA methylation has emerged as an important predictor of age, leading to the development of epigenetic clocks that quantify the extent of pathological deterioration beyond what is typically expected for a given age. Machine learning technologies offer promising avenues to enhance our understanding of the biological mechanisms governing aging by further elucidating the gap between biological and chronological ages. This perspective article examines current algorithmic approaches to epigenetic clocks, explores the use of machine learning for age estimation from DNA methylation, and discusses how refining the interpretation of ML methods and tailoring their inferences for specific patient populations and cell types can amplify the utility of these technologies in age prediction. By harnessing insights from machine learning, we are well-positioned to effectively adapt, customize and personalize interventions aimed at aging.

Indexed as

AgingDNA MethylationEpigenesis, GeneticMachine LearningArtificial IntelligenceEpigenomicsHumansagingartificial intelligenceclassification and regression treesclocksdeep learningDNA methylationepigeneticsexplainability

Identifiers

PMID39584810
PMCPMC11703013

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.